Home > PB Ratio > VENUS REMEDIES

VENUS REMEDIES
PB (Price/Book ) Ratio

The Current P/B Ratio of VENUS REMEDIES is 0.80.

Share Price ₹289.5Jan 29,2025
Market Cap ₹387.9 Cr
Book Value₹487.6 CrMar2024 - Consolidated Results
Price/Book 0.80xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results
VENUS REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of VENUS REMEDIES

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of VENUS REMEDIES is calculated as :

Current Market Cap [ ₹387.9 Cr] as on Jan 29,2025

(/) Book Value [ ₹487.6 Cr] based on Mar2024 - Consolidated Results

(=) P/B Ratio [ 0.80x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for VENUS REMEDIES , the investors are currently willing to pay '0.80 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of VENUS REMEDIES !

The chart below summarizes the trend in P/B Ratio of VENUS REMEDIES over the last five years.

Historical PB (Price/Book ) ratio chart of VENUS REMEDIES


PB Ratio Performance Analysis for VENUS REMEDIES

- VENUS REMEDIES 's latest p/b ratio is 0.80x.

- VENUS REMEDIES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.63x.

- VENUS REMEDIES 's operated at median p/b ratio of 0.82x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/b ratio peaked in Mar2024 at 0.89x.

- VENUS REMEDIES 's p/b ratio hit its five-year low in Mar2020 of 0.09x.


How does VENUS REMEDIES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
VENUS REMEDIES 487.550.80387.9
SUN PHARMACEUTICAL INDUSTRIES LTD63,666.806.54416,692.0
CIPLA LTD26,619.904.32115,000.0
DR REDDYS LABORATORIES LTD28,123.503.5198,616.4
ZYDUS LIFESCIENCES LTD19,829.504.7393,841.4
DIVIS LABORATORIES LTD13,571.0011.00149,215.0
MANKIND PHARMA LTD9,339.8410.95102,232.0
TORRENT PHARMACEUTICALS LTD6,856.1516.58113,701.0
LUPIN LTD14,175.806.6594,337.9
AUROBINDO PHARMA LTD29,842.802.2567,192.9
ABBOTT INDIA LTD3,658.7314.8054,136.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs VENUS REMEDIES 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 0.80x
Max industry PB 16.58x
Median industry PB 6.54x
Average industry PB 7.47x



You may also like the below Video Courses